Patient Safety and Quality Improvement Act of 2005

The Annals of Pharmacotherapy
William E Fassett

Abstract

To review Public Law (PL) 109-41-the Patient Safety and Quality Improvement Act of 2005 (PSQIA)-and summarize key medication error research that contributed to congressional recognition of the need for this legislation. Relevant publications related to medication error research, patient safety programs, and the legislative history of and commentary on PL 109-41, published in English, were identified by MEDLINE, PREMEDLINE, Thomas (Library of Congress), and Internet search engine-assisted searches using the terms healthcare quality, medication error, patient safety, PL 109-41, and quality improvement. Additional citations were identified from references cited in related publications. All relevant publications were reviewed. Summarization of the PSQIA was carried out by legal textual analysis. PL 109-41 provides privilege and confidentiality for patient safety work product (PSWP) developed for reporting to patient safety organizations (PSOs). It does not establish federal mandatory reporting of significant errors; rather, it relies on existing state reporting systems. The Act does not preempt stronger state protections for PSWP. The Agency for Healthcare Research and Quality is directed to certify PSOs and promote the establishme...Continue Reading

References

Dec 1, 1992·The Annals of Pharmacotherapy·M T Rupp
May 1, 1986·Drug Intelligence & Clinical Pharmacy·D E Francke
Jun 16, 1966·The New England Journal of Medicine·H K Beecher
Oct 1, 1983·Drug Intelligence & Clinical Pharmacy·B G GuernseyE Galvan
Jul 1, 1993·The Annals of Pharmacotherapy·T R Einarson
Nov 8, 1978·Drug Intelligence & Clinical Pharmacy·J E StewartA I Wertheimer
Aug 10, 1978·Drug Intelligence & Clinical Pharmacy·D V Lundin
Oct 9, 1979·Drug Intelligence & Clinical Pharmacy·G F Archambault
Mar 17, 2000·BMJ : British Medical Journal·R L Helmreich
Oct 13, 2000·Journal of the American Pharmaceutical Association : APhA·D B ChristensenA Stergachis
Jul 12, 2001·Sozial- Und Präventivmedizin·T Abelin
Sep 7, 2001·The International Journal of Aviation Psychology·R L HelmreichJ A Wilhelm
Jan 31, 2002·The Journal of School Health·M K Tappe, R A Galer-Unti
Mar 13, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Elizabeth A FlynnRobert L Mikeal
Jul 18, 2003·The Journal of General Virology·Kate AspdenAnna-Lise Williamson
Aug 27, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Donna Young

❮ Previous
Next ❯

Citations

Nov 7, 2007·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Jacqueline Ross
Sep 7, 2007·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·John R ClarkeWilliam Marella
May 7, 2010·Scandinavian Journal of Caring Sciences·Hanna LewénJan Nilsson
Feb 11, 2019·Rapid Communications in Mass Spectrometry : RCM·Shanshan ZhaoShuming Yang
Jan 28, 2010·Journal of Health Services Research & Policy·Maggie PeatUNKNOWN PIPS Group
Jun 20, 2008·Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses·Kathleen Catalano
Sep 28, 2020·Joint Commission Journal on Quality and Patient Safety·Anjana E SharmaUrmimala Sarkar
Mar 17, 2021·Journal of the American Pharmacists Association : JAPhA·Ana L HincapieNeil J MacKinnon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.